Kaiser Permanente Ventures — 2020 Investments
4 investments dated 2020 · listed companies and verified rows first · show all
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.
BiotechHealthtechLongevityRichmond, US
Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Kristen Fortney(Founder)inEric Morgen(Founder)inDov Goldstein(Executive Officer)in
BoardPatrick Enright(Director)in
Co-investorsAndreessen HorowitzElad GilFelicis VenturesGreen Sands EquityIA Seed VenturesLongitude Capital+19 more
Osso develops virtual reality training scenarios for nurses, nurse leaders and healthcare system administrators, offering self-guided learning, skill assessment, and collaborative training on one platform.
Digital HealthEdTechHealthtechMillbrae, US
Justin Barad(Founder)inHeather Gervais(CEO)inHarvard-trained pediatric(Founder)Matt Newport(Founder)
Board seatAmy Belt Raimundo· per SEC Form D
Co-investorsInformed Ventures Advisors, LlcOak HC/FTPresence CapitalScrum VenturesSignalFireAnorak Ventures+1 more
Ordr provides a device intelligence and network security platform that identifies and protects connected assets across cloud, on-premises, and SaaS environments.
Cloud ComputingCybersecurityEnterprise SoftwareIoT
Pandian Gnanaprakasam(Founder)Sheausong Yang(Founder)
Co-investorsBattery VenturesTen ElevenUnusual VenturesWing
App to improve mental health and insomnia
Co-investorsGilde HealthcareIndex VenturesOctopus VenturesSamsung Next
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
























